These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2533479)

  • 1. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.
    Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T
    Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
    Yoshida N; Ito T; Karasawa T; Itoh Z
    J Pharmacol Exp Ther; 1991 May; 257(2):781-7. PubMed ID: 2033519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
    Linnik MD; Butler BT; Gaddis RR; Ahmed NK
    J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl] benzamide citrate (AS-4370) and related compounds.
    Kato S; Morie T; Kon T; Yoshida N; Karasawa T; Matsumoto J
    J Med Chem; 1991 Feb; 34(2):616-24. PubMed ID: 1995885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzamides as selective and potent gastrokinetic agents. III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy- and 2-ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides.
    Kato S; Morie T; Harada H; Yoshida N; Matsumoto J
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):652-60. PubMed ID: 1535291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
    Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
    Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J
    J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig.
    Schuurkes JA; Van Nueten JM; Van Daele PG; Reyntjens AJ; Janssen PA
    J Pharmacol Exp Ther; 1985 Sep; 234(3):775-83. PubMed ID: 3897516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
    Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
    Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
    Takeda K; Taniyama K; Kuno T; Sano I; Ishikawa T; Ohmura I; Tanaka C
    J Pharmacol Exp Ther; 1991 May; 257(2):806-11. PubMed ID: 1851838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beer congener stimulates gastrointestinal motility via the muscarinic acetylcholine receptors.
    Fujii W; Hori H; Yokoo Y; Suwa Y; Nukaya H; Taniyama K
    Alcohol Clin Exp Res; 2002 May; 26(5):677-81. PubMed ID: 12045476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
    Gylys JA; Wright RN; Nicolosi WD; Buyniski JP; Crenshaw RR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):830-7. PubMed ID: 2978041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzamides as selective and potent gastrokinetic agents. IV. Synthesis and structure-activity relationships of 2-substituted 4-amino-N-[(4-benzyl-2-morpholinyl)methyl]-5-chlorobenzamides.
    Kato S; Morie T; Yoshida N; Matsumoto J
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1470-5. PubMed ID: 1394664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.